OXT and craniopharyngioma: Damage to the hypothalamus from craniopharyngiomas and other tumours will result in disruption of POMC activation of PVH magnocellular oxytocin neurons and the release of oxytocin via α-melanocyte stimulating hormone and will thus abrogate the anorexigenic effect of oxytocin (116, 117).